Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals. | Commun Biol | 2022 | 35697829 | PubTator, text mining | PubMed |
| Oral Glucose Tolerance Test: An Informative Endpoint or an Added Burden in Metformin Drug-Drug Interaction Studies? | Clin Pharmacol Ther | 2022 | 35687738 | PubTator, text mining | PubMed |
| Nanomaterials for Inner Ear Diseases: Challenges, Limitations and Opportunities. | Materials (Basel) | 2022 | 35683076 | PubTator, text mining | PubMed |
| Physiology, Biochemistry and Pharmacology of Transporters for Organic Cations 2.0. | Int J Mol Sci | 2022 | 35683007 | PubTator, text mining | PubMed |
| The Rationale for "Laser-Induced Thermal Therapy (LITT) and Intratumoral Cisplatin" Approach for Cancer Treatment. | Int J Mol Sci | 2022 | 35682611 | PubTator, text mining | PubMed |
| Antioxidant activity and α-glucosidase inhibitability of Distichochlamys citrea M.F. Newman rhizome fractionated extracts: in vitro and in silico screenings. | Chem Zvesti | 2022 | 35669698 | PubTator, text mining | PubMed |
| Morphine-3-Glucuronide, Physiology and Behavior. | Front Mol Neurosci | 2022 | 35645730 | PubTator, text mining | PubMed |
| Filgotinib: A Clinical Pharmacology Review. | Clin Pharmacokinet | 2022 | 35637376 | PubTator, text mining | PubMed |
| Corrigendum to "The role of cholesterol recognition (CARC/CRAC) mirror codes in the allosterism of the human organic cation transporter 2 (OCT2, SLC22A2)" [Biochem. Pharmacol. 194 (2021) 114840]. | Biochem Pharmacol | 2022 | 35635891 | PubTator, text mining | PubMed |
| Reversibility of Central Nervous System Adverse Events in Course of Art. | Viruses | 2022 | 35632768 | PubTator, text mining | PubMed |
| Nimodipine Treatment Protects Auditory Hair Cells from Cisplatin-Induced Cell Death Accompanied by Upregulation of LMO4. | Int J Mol Sci | 2022 | 35628594 | PubTator, text mining | PubMed |
| COUP-TFII in Kidneys, from Embryos to Sick Adults. | Diagnostics (Basel) | 2022 | 35626336 | PubTator, text mining | PubMed |
| Blockade LAT1 Mediates Methionine Metabolism to Overcome Oxaliplatin Resistance under Hypoxia in Renal Cell Carcinoma. | Cancers (Basel) | 2022 | 35626154 | PubTator, text mining | PubMed |
| Molecular Basis Underlying Hepatobiliary and Renal Excretion of Phenolic Acids of Salvia miltiorrhiza Roots (Danshen). | Front Pharmacol | 2022 | 35620286 | PubTator, text mining | PubMed |
| Assessing the Roles of Molecular Markers of Antimalarial Drug Resistance and the Host Pharmacogenetics in Drug-Resistant Malaria. | J Trop Med | 2022 | 35620049 | PubTator, text mining | PubMed |
| Challenges and Opportunities for Improved Drug-Drug Interaction Predictions for Renal OCT2 and MATE1/2-K Transporters. | Clin Pharmacol Ther | 2022 | 35598119 | PubTator, text mining | PubMed |
| Pharmacokinetics, distribution, and excretion of sodium oligomannate, a recently approved anti-Alzheimer's disease drug in China. | J Pharm Anal | 2022 | 35573885 | PubTator, text mining | PubMed |
| Supporting Cells and Their Potential Roles in Cisplatin-Induced Ototoxicity. | Front Neurosci | 2022 | 35573297 | PubTator, text mining | PubMed |
| Cloning and Functional Characterization of Dog OCT1 and OCT2: Another Step in Exploring Species Differences in Organic Cation Transporters. | Int J Mol Sci | 2022 | 35563491 | PubTator, text mining | PubMed |
| A Comprehensive Review on the Chemical Properties, Plant Sources, Pharmacological Activities, Pharmacokinetic and Toxicological Characteristics of Tetrahydropalmatine. | Front Pharmacol | 2022 | 35559252 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=27